Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches
Pierluigi Reveglia, Carmela Paolillo, Gabriella Ferretti, et al.
Metabolomics (2021) Vol. 17, Iss. 9
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Integrative multi-omics and systems bioinformatics in translational neuroscience: A data mining perspective
Lance M. O’Connor, Blake A. O’Connor, Su Bin Lim, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 8, pp. 836-850
Open Access | Times Cited: 48
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Simone Lista, Raúl González‐Domínguez, Susana López‐Ortiz, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101987-101987
Closed Access | Times Cited: 33
Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations
L. Krishaa, Ted Kheng Siang Ng, Hai Ning Wee, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111787-111787
Open Access | Times Cited: 30
Multiplatform Untargeted Metabolomics
Micah J. Jeppesen, Robert Powers
Magnetic Resonance in Chemistry (2023) Vol. 61, Iss. 12, pp. 628-653
Open Access | Times Cited: 28
Danggui Shaoyao San: comprehensive modulation of the microbiota-gut-brain axis for attenuating Alzheimer’s disease-related pathology
Jiawei He, Yijie Jin, Chunxiang He, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 13
Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?
Begoña Talavera Andújar, Arnaud Mary, Carmen Venegas, et al.
Environmental Science & Technology (2024)
Open Access | Times Cited: 9
Small molecule biomarker discovery: Proposed workflow for LC-MS-based clinical research projects
Samuel Rischke, Lisa Hahnefeld, Bo Burla, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2023) Vol. 28, pp. 47-55
Open Access | Times Cited: 19
Gut instincts: Unveiling the connection between gut microbiota and Alzheimer's disease
Vasu Peddinti, Manoj Mohan Avaghade, Sunil Suthar, et al.
Clinical Nutrition ESPEN (2024) Vol. 60, pp. 266-280
Closed Access | Times Cited: 7
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
Oneil G. Bhalala, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1231-1231
Open Access | Times Cited: 6
Recent review on selected xenobiotics and their impacts on gut microbiome and metabolome
Yan Jin, Jinhua Chi, Kaelene LoMonaco, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117155-117155
Open Access | Times Cited: 14
Advancing personalized medicine: Integrating statistical algorithms with omics and nano-omics for enhanced diagnostic accuracy and treatment efficacy
Abdurrahman Coşkun, Gökhan Ertaylan, Murih Pusparum, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167339-167339
Closed Access | Times Cited: 5
Current strategies of detecting Aβ species and inhibiting Aβ aggregation: Status and prospects
Jun Li, Wang Liao, Dongqing Huang, et al.
Coordination Chemistry Reviews (2023) Vol. 495, pp. 215375-215375
Closed Access | Times Cited: 12
Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer’s disease (from the Nakayama Study)
Tomoki Ozaki, Yuta Yoshino, Ayumi Tachibana, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer’s Disease
Pierluigi Reveglia, Carmela Paolillo, Antonella Angiolillo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9736-9736
Open Access | Times Cited: 9
CSF amino acid profiles in ICV‐streptozotocin‐induced sporadic Alzheimer's disease in male Wistar rat: a metabolomics and systems biology perspective
Amir Barzegar Behrooz, Hamid Latifi‐Navid, Jabar Lotfi, et al.
FEBS Open Bio (2024) Vol. 14, Iss. 7, pp. 1116-1132
Open Access | Times Cited: 3
Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases
Stefania Briganti, Mauro Truglio, Antonella Angiolillo, et al.
Metabolites (2021) Vol. 11, Iss. 12, pp. 819-819
Open Access | Times Cited: 21
Deep learning analysis of UPLC-MS/MS-based metabolomics data to predict Alzheimer's disease
Kesheng Wang, Laurie A. Theeke, Christopher Liao, et al.
Journal of the Neurological Sciences (2023) Vol. 453, pp. 120812-120812
Open Access | Times Cited: 8
Advances in peripheral blood biomarkers of patients with Alzheimer’s disease: Moving closer to personalized therapies
Gabriella Ferretti, Sara Serafini, Antonella Angiolillo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115094-115094
Open Access | Times Cited: 6
Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer's disease and synucleinopathies
Stefano L. Sensi, Mirella Russo, Pietro Tiraboschi
Handbook of clinical neurology (2023), pp. 187-218
Closed Access | Times Cited: 4
Can Small Molecules Provide Clues on Disease Progression in Cerebrospinal Fluid from Mild Cognitive Impairment and Alzheimer’s Disease Patients?
Begoña Talavera Andújar, Arnaud Mary, Carmen Venegas, et al.
(2024)
Open Access | Times Cited: 1
Pathology-specific lipid alterations with triacylglycerol as a potential biomarker in Focal cortical dysplasia (FCD) and Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS)
Nitin Yadav, Sneha Anand, Krishan Kumar, et al.
Neuroscience (2024) Vol. 566, pp. 72-86
Closed Access | Times Cited: 1
Therapeutic effect and mechanism of Anemarrhenae Rhizoma on Alzheimer’s disease based on multi-platform metabolomics analyses
Hui Wang, Jianying Dai, Yu-Zhen He, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
High‐Fat Diet Alters Acylcarnitine Metabolism of the Retina and Retinal Pigment Epithelium/Choroidal Tissues in Laser‐Induced Choroidal Neovascularization Rat Models
Pinghui Wei, Meiqin He, Ying Wang, et al.
Molecular Nutrition & Food Research (2023) Vol. 67, Iss. 19
Closed Access | Times Cited: 3
Exploring Cinnamic Acids as Potent Antimetastatic Agents for Cancer Therapy: Molecular Docking and Dynamic Simulation against MMP2
Setareh Shojaei, Mohammad-Reza Zandieh, Shokoofeh Jamshidi, et al.
European Journal of Cancer Care (2024) Vol. 2024, pp. 1-19
Open Access
Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis
Zhenyan Song, Jiawei He, Wenjing Yu, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top